Anthropic says it has spent months in research partnerships with six drug developers, including Bristol Myers Squibb and BigHat Biosciences, and has begun drug discovery of its own, including acquiring Mithril Medicine, whose founder used Claude and 11 out...
VQV Signal
RESEARCH
WATCH
TECHNICAL
Anthropic starts its own drug discovery and buys a one-person biotech
Anthropic says it has spent months in research partnerships with six drug developers, including Bristol Myers Squibb and BigHat Biosciences, and has begun drug discovery of its own, including acquiring Mithril Medicine, whose founder used Claude and 11 out...
Anthropic says it has spent months in research partnerships with six drug developers, including Bristol Myers Squibb and BigHat Biosciences, and has begun drug discovery of its own, including acquiring Mithril Medicine, whose founder used Claude and 11 outside labs to take a possible muscular dystrophy treatment...
VQV organizes public signals from inspectable sources. It does not independently verify the underlying report.
Signal Strength 80%
Technical label WATCH
Public Interest 46
Category RESEARCH
Reader Depth TECHNICAL
Signal Strength reflects source quality, relevance, freshness and evidence. Public Interest helps organize discovery; it is not proof of truth.
Public Interest components
Recognizable Entity Score 82
Practical Impact Score 20
Novelty Interest Score 70
Consequence Score 10
Curiosity Score 0
Shareability Score 63
VQV surfaced this signal because it is recent, relevant to Consumer AI, connected to Scobleizer News Pulse (X).
No login, cookies, social SDKs, or automatic posting.